Connection
Sean Colgan to Prolyl-Hydroxylase Inhibitors
This is a "connection" page, showing publications Sean Colgan has written about Prolyl-Hydroxylase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.173 |
|
|
|
-
Wang RX, Henen MA, Lee JS, V?geli B, Colgan SP. Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor. Gut Microbes. 2021 Jan-Dec; 13(1):1938380.
Score: 0.738
-
Keely S, Campbell EL, Baird AW, Hansbro PM, Shalwitz RA, Kotsakis A, McNamee EN, Eltzschig HK, Kominsky DJ, Colgan SP. Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis. Mucosal Immunol. 2014 Jan; 7(1):114-23.
Score: 0.435